Related Experiment Video
Updated: May 3, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Measuring antimicrobial use in hospitalized patients: a systematic review of available measures applicable to
E Fortin1, P S Fontela2, A R Manges3
1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Canada Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Québec and Montréal, Canada.
Insights
The best way to track antimicrobial use in hospitals, including for children, is still unclear. This review found 26 different measures, but none definitively predict antimicrobial resistance.
Area of Science:
- Healthcare Epidemiology
- Infectious Diseases
- Pediatric Health
Background:
- Accurate surveillance of antimicrobial usage is critical for combating antimicrobial resistance.
- Existing measures for tracking antimicrobial consumption in hospital settings, particularly those including pediatric populations, lack definitive validation.
- Understanding the optimal metric is essential for effective antimicrobial stewardship programs.
Purpose of the Study:
- To systematically review and compare existing measures of antimicrobial use applied in settings with pediatric inpatients.
- To identify and define various antimicrobial usage metrics used in literature.
- To provide a foundation for selecting the most effective measure for surveillance and resistance prediction.
Main Methods:
- Systematic literature search of MEDLINE, EMBASE, CINAHL, and LILACS (1975-2011) and citation tracking.
- Inclusion of cohort studies and repeated point-prevalence studies involving hospitalized pediatric patients.
- Independent data extraction by two reviewers on study characteristics and antimicrobial measure comparisons.
Main Results:
- Seventy-nine studies met selection criteria, identifying 26 distinct antimicrobial usage measures.
- The most common measures were defined daily doses (DDD)/patient-days and exposed patients/patients.
- Limited quantitative comparisons showed correlations between different metrics, with doses/patient-days showing a stronger link to resistance rates.
Conclusions:
- The optimal measure for antimicrobial use surveillance that best predicts antimicrobial resistance has not yet been identified.
- Further research is necessary to establish evidence-based recommendations for antimicrobial usage metrics.
- The findings highlight the need for standardized and validated measures in pediatric and general hospital settings.
Objectives:
The optimal measure to use for surveillance of antimicrobial usage in hospital settings, especially when including paediatric populations, is unknown. This systematic review of literature aims to list, define and compare existing measures of antimicrobial use that have been applied in settings that included paediatric inpatients, to complement surveillance of resistance.
Methods:
We identified cohort studies and repeated point-prevalence studies presenting data on antimicrobial use in populations of inpatients or validations/comparisons of antimicrobial measures through a systematic search of literature using MEDLINE, EMBASE, CINAHL and LILACS (1975-2011) and citation tracking. Study populations needed to include hospitalized paediatric patients. Two reviewers independently extracted data on study characteristics and results.
Results:
Overall, 3878 records were screened and 79 studies met selection criteria. Twenty-six distinct measures were found, the most frequently used being defined daily doses (DDD)/patient-days and exposed patients/patients. Only two studies compared different measures quantitatively, showing (i) a positive correlation between proportion of exposed patients and antimicrobial-days/patient-days and (ii) a strong correlation between doses/patient-days and agent-days/patient-days (r = 0.98), with doses/patient-days correlating more with resistance rates (r = 0.80 versus 0.55).
Conclusions:
The measure of antimicrobial use that best predicts antimicrobial resistance prevalence and rates, for surveillance purposes, has still not been identified; additional evidence on this topic is a necessity.
More Related Videos
06:18Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
Published on: December 14, 2020
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antimicrobial Effectiveness
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution